|
Interferon beta-1a
Product Approval Information - Licensing Action
Proper name: Interferon beta-1a
Tradename: Avonex
Manufacturer: Biogen, Inc, Cambridge, MA, License #1204
Indication for Use: Treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations
Approval Date: 5/17/96
Type of submission: Product license application
Approval Letter (PDF),
(Text)
Label (PDF)
SBA (PDF)
Last Updated: 3/5/2001
 Back
to Top 
Back to Index
Date created: September 23, 2003 |
